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KESAN MADU LEBAH TUALANG TERHADAP INTOKSIKASI 
PARAKUAT PADA TIKUS 
ABSTRAK 
Parakuat (PQ) adalah sejenis racun herba yang digunakan dengan meluas di seluruh 
dunia dan telah dipostulasi menunjukkan kesan toksik melalui penghasilan pelbagai 
spesies oksigen reaktif berikutan dengan kerosakan oksidatif pada komponen utama 
sel. Madu lebah Tualang (TH) dilaporkan mempunyai sifat antioksidan dan 
berkemungkinan membantu memperbaiki kerosakan oksidatif dalam kes keracunan 
PQ. Oleh itu, objektif utama kajian ini adalah untuk menilai kesan perlindungan 
madu TH pada ketoksikan akut (kajian 1) dan subakut PQ (kajian 2) di kalangan 
tikus. Tikus jantan Sprague-Dawley berusia lapan minggu digunakan. Pada kajian 1, 
dos oral PQ dan TH ditentukan pada 225 mg/kg dan 0.2 g/kg, masing-masing. Kesan 
rawatan TH tunggal dan berulang seterusnya dikaji: kumpulan rawatan tunggal 
menerima TH pada 0.5 (PQ + TH0.5h), 2 (PQ + TH2h) atau 6 (PQ + TH6h) jam 
selepas pemberian PQ; kumpulan rawatan berulang menerima TH pada 0.5, 2 dan 6 
jam (PQ + THtrp) atau rawatan diteruskan sebanyak sekali sehari untuk enam hari 
berterusan (PQ + TH7d), masing-masing. Masa mandiri untuk setiap tikus dicatat 
sehingga hari ke-28 sebelum ia dikorbankan. Rawatan dengan TH tidak dapat 
menambah baik kadar kemandirian tikus yang diracunkan oleh PQ. Namun 
demikian, kumpulan tikus yang menerima rawatan berulang menunjukkan masa 
mandiri median yang lebih panjang secara signifikan berbanding dengan kumpulan 
PQ + TH6h.  Rawatan dengan TH juga menambah baik hasil histologi pada tikus 
yang diracunkan dengan PQ terutamanya pada peparu yang mencadangkan bahawa 
kemungkinan kegunaan TH dapat melambatkan kesan toksik PQ. Pada kajian 2,  
kesan perlindungan TH pada tekanan oksidatif aruhan PQ pada otak tengah dan 
xix 
peparu dikaji. Tikus dirawat dengan air suling (kumpulan N dan PQ; 2 mL/kg/hari), 
TH (kumpulan TH dan PQ + TH; 1.0 g/kg/hari) atau ubiquinol (PQ + QH; 0.2 
g/kg/hari) setiap hari sepanjang masa kajian. Dua minggu selepas rawatan masing-
masing, tikus diberikan larutan salin (N dan TH; 1 mL/kg/minggu, i.p) atau PQ (PQ, 
PQ + TH dan PQ + QH; 10 mg/kg/minggu, i.p) seminggu sekali selama empat 
minggu berterusan. Tikus dikorbankan seminggu selepas suntikan terakhir salin atau 
PQ. Hasil kajian menunjukkan bahawa kumpulan yang menerima TH (TH dan PQ + 
TH) atau ubiquinol (PQ + QH) mengandungi kandungan urea serum yang lebih 
rendah (p < 0.05). Kreatinina serum juga menurun secara signifikan di dalam  
kumpulan PQ + TH berbanding dengan kumpulan kawalan N dan TH. Kandungan 
ALT yang lebih rendah (p < 0.05) juga dilihat pada kumpulan TH dan PQ + TH 
apabila dibandingkan dengan kumpulan PQ. Perubahan ini mencadangkan bahawa 
rawatan TH mungkin memberikan kesan bermanfaat terhadap fungsi ginjal dan hati 
tikus. Berikutan pemberian PQ empat mingguan, aktiviti GPx otak tengah menurun 
secara signifikan. Kerosakan neuron dopaminergik akibat aruhan PQ dilihat apabila 
terdapat pengurangan signifikan bilangan neuron tirosina hidroksilase-imunopositif 
di kawasan substantia nigra pars compacta otak tengah. Penurunan signifikan 
aktiviti-aktiviti SOD dan GST di peparu juga diperhatikan pada kumpulan PQ 
berbanding dengan kumpulan N. Secara keseluruhan, rawatan TH dapat 
memperbaiki kesan-kesan toksik yang dilihat di otak tengah dan peparu, di mana 
kesan perlindungan TH adalah setanding dengan ubiquinol, ubat kawalan yang 
digunakan dalam kajian 2. Hasil kajian mencadangkan bahawa rawatan TH dapat 
memberi kesan perlindungan terhadap ketoksikan subakut PQ. Kesan ini mungkin 
berlaku akibat sifat antioksidan yang dimiliki TH. 
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EFFECTS OF TUALANG HONEY ON PARAQUAT INTOXICATION  
IN RATS  
ABSTRACT 
Paraquat (PQ) is an herbicide widely used in the world and has been postulated to 
exert its toxic effects via the production of various reactive oxygen species causing 
subsequent oxidative damage at key cellular components. Tualang honey (TH) has 
been reported to possess good antioxidant properties and may help ameliorate the 
oxidative damages in case of PQ poisoning. Therefore, the main objectives of this 
study were to evaluate the possible protective effect of TH in acute (study 1) and 
subacute (study 2) PQ toxicities in rats. Male Sprague-Dawley rats aged eight weeks 
old were used. In study 1, selected oral doses of PQ and TH were 225 mg/kg and 0.2 
g/kg, respectively. The effects of single and multiple TH treatments on PQ-
intoxicated rats were then investigated: single TH treatment groups received TH at 
0.5 (PQ + TH0.5h), 2 (PQ + TH2h) or 6 (PQ + TH6h) hours following PQ 
administration; multiple TH treatment groups received TH at 0.5, 2 and 6 hours (PQ 
+ THtrp) or further daily treatment for next six days (PQ + TH7d) following PQ 
administration, respectively (n = 6 per group). The survival time of each rat was 
recorded until day 28 before sacrifice. Although treatment with TH did not improve 
the survival rate of PQ-intoxicated rats, the median survival time of rats which 
received multiple TH treatments was significantly longer when compared to group 
PQ + TH6h. Furthermore, TH treatment improved the histological outcome of PQ-
intoxicated rats particularly in the lungs, thus suggesting the potential role of honey 
in delaying the toxic effects of PQ. In study 2, the protective effect of TH on PQ-
induced oxidative stress in rats’ midbrain and lung regions were investigated (n= 15 
per group). The rats were orally treated with distilled water (Groups N & PQ, 2 
xxi 
mL/kg/day), TH (Groups TH & PQ + TH, 1.0 g/kg/day) or ubiquinol (Group PQ + 
QH, 0.2 g/kg/day) throughout the experimental period. Two weeks after the 
respective treatments, the rats were administered with saline (Groups N & TH; 1 
mL/kg/week, i.p) or PQ (10 mg/kg/week, i.p.; Groups PQ, PQ + TH and PQ + QH) 
once a week for four consecutive weeks. The animals were then sacrificed a week 
following the final injection of saline or PQ. Serum urea was significantly lower in 
groups which received TH (TH and PQ + TH) or ubiquinol (PQ + QH). Serum 
creatinine was markedly reduced in group PQ + TH as well, when compared to 
controls (N and TH). Significantly lower levels of ALT were observed in groups TH 
and PQ + TH when compared to group PQ. These findings suggest that TH treatment 
may have some beneficial effects on the kidney and liver’s function. Following four-
weekly PQ-administration, the midbrain GPx activity was significantly reduced 
when compared to healthy control (N). PQ-induced dopaminergic neuronal damage 
was demonstrated by a significant reduction in the number of tyrosine hydroxylase-
immunopositive neurons in the midbrain substantia nigra pars compacta while in the 
lungs, marked reduction in the activities of SOD and GST were observed in group 
PQ when compared to the control group. Treatment with TH ameliorates the toxic 
effects seen in the midbrain and lungs with comparable effects to ubiquinol, the 
control drug used in study 2. These findings suggest that pre-treatment with TH 
showed some protective effects against subacute PQ toxicities. It is plausible that the 
protective effects of TH are conferred by its antioxidant properties. 
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CHAPTER 1  
INTRODUCTION 
1.1 RESEARCH BACKGROUND 
Problems resulting from paraquat (PQ) exposure are reported all over the world and 
are mainly caused by suicidal intent, accidental poisoning or occupational exposures 
(Eddleston and Bateman, 2007; IPCS, 1991). PQ is known to be a producer of 
various reactive oxygen species (ROS) via single electron redox cycle in vivo 
(Abdollahi et al., 2004; Autor et al., 1977; Bus and Gibson, 1984). ROS readily 
attacks key cellular structures and molecules (lipids, carbohydrates, proteins and 
nucleotides) thus causing cellular deleterious effects which formed the basis of 
various disease conditions (Halliwell, 2009; Slater, 1984; Valko et al., 2007).  
 
In acute toxicity, high concentrations of PQ often lead to death due to multi-organ 
failures with major pneumotoxic effects seen (Bismuth et al., 1990; Dinis-Oliveira et 
al., 2007a; Fung et al., 1999; Ghazi-Khansari et al., 2005; Krieger, 2001). PQ is 
selectively concentrated in the lungs where the high alveolar oxygen content further 
increase the degree of lung injury by oxidative damage and exerts its major 
pneumotoxic effects in acute poisoning, thus producing diffuse alveolitis and loss of 
surfactant followed by progressive pulmonary fibrosis (Bismuth et al., 1990; Yeh et 
al., 2006). Similar effects may also occur in other major organ systems that 
eventually lead to death in the animals from multiple organ failure. In fact, ingestion 
of high doses of PQ usually leads to death from multi-organ failures. Smaller 
ingestion doses may also lead to delayed death as a result of extensive pulmonary 
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fibrosis and respiratory failure (Dinis-Oliveira et al., 2006b; Suntres, 2002). 
Conventional approach in treatment of PQ poisoning focused on three main areas 
which include prevention of absorption from the gastrointestinal tract, enhancement 
of elimination of PQ from the body and administration of therapies directed against 
toxicity. Nevertheless, these treatment methods have been disappointing and the 
mortality rate remained very high (Eddleston and Bateman, 2007; Franzen et al., 
1991; Gawarammana and Buckley, 2011; Lin et al., 1996).  
 
On the other hand, unlike the major pneumotoxic effects occurring during acute 
poisoning, repeated low dose exposures to PQ is believed to be neurotoxic (Cicchetti 
et al., 2005; Dinis-Oliveira et al., 2006a; Franco et al., 2010; Hatcher et al., 2008). 
The effects of chronic exposure to PQ have gained considerable attention due to its 
wide usage around the world particularly among agricultural workers and PQ 
formulation workers (Cannon and Greenamyre, 2011; Drechsel and Patel, 2008; 
Tanner et al., 2011). More alarmingly, there are growing evidences from 
epidemiological studies which implicated the possible involvement of environmental 
toxin such as pesticides as an aetiological factor for Parkinson’s disease (Franco et 
al., 2010; Hatcher et al., 2008; McCormack et al., 2002; Semchuk et al., 1993).  
 
Studies conducted by Hertzman et al. (1990) and Liou et al. (1997) indicated that 
exposure to PQ are associated with higher incidence of Parkinson’s Disease. PQ-
induced oxidative stress has been demonstrated in the substantia nigra region of 
Parkinson’s disease brain (Franco et al., 2010). A study by Ranjbar et al. (2002) 
reported that workers from PQ formulating factory are also at higher risk of having 
an oxidative stress as evidenced by elevated lipid peroxidation and decreased of 
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antioxidant power. In experimental models, rats or mice exposed to PQ demonstrate 
a selective degeneration of nigrostriatal dopaminergic neurons, one of the 
neuropathological hallmark of Parkinson’s disease (Brooks et al., 1999; Kang et al., 
2010; Kuter et al., 2007; LeDoux, 2005; McCormack et al., 2006).  
 
Since the main suggested mechanism for PQ toxicity, either acute or chronic, 
involves the production of ROS, it may be hypothesized that an antidote against PQ 
poisoning should be a substance with good antioxidant properties. Honey is known to 
be rich in both enzymatic and non-enzymatic antioxidants. It contains both aqueous 
and lipophilic antioxidants with the interaction between these antioxidants suggesting 
its potential as an ideal natural antioxidant that can act at different cellular sites in the 
case of PQ poisoning (Angela, 2003; Küçük et al., 2007; Nagai et al., 2006).  
 
Tualang honey is a wild honey harvested from the Tualang trees found in the 
Malaysia rain forest. Various studies have been conducted in an effort to evaluate the 
possible medicinal uses of Tualang honey including investigating its anti-cancer 
properties in cell culture and animal model (Fauzi et al., 2011; Ghashm et al., 2010), 
the protective effects of honey from cigarette smokes’ damage (Mohamed et al., 
2011b), animal menopausal model (Zaid et al., 2010), anti-diabetic properties 
(Erejuwa et al., 2009; Erejuwa et al., 2010a; Erejuwa et al., 2010b) as well as in 
wound management and as an antimicrobial (Khoo et al., 2010; Nasir et al., 2010; 
Tan et al., 2009). In addition, the neuroprotective effects of Tualang honey have also 
been previously reported in chronic cerebral hypoperfusion-induced 
neurodegeneration in the hippocampus of rats (Saxena et al., 2014). Supplementation 
of Tualang honey improved the hippocampal and medial prefrontal cortex 
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morphology, memory performances and cholinergic system in stressed 
ovariectomised rats (Al-Rahbi et al., 2014a; Al-Rahbi et al., 2014b). One of the 
purported mechanisms of action is mainly contributed by its antioxidant properties.  
 
A study by Mohamed et al. (2010) showed that Tualang honey contains phenolic 
compounds with good antioxidant activities. However, to date the protective effects 
of honey on PQ toxicity have not been investigated. Therefore, the main purpose of 
this study is to evaluate the possible protective effects of Tualang honey on PQ-
induced acute toxicity (study 1) and subacute toxicity (study 2) in Sprague-Dawley 
rats.  
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1.2 OBJECTIVES 
1.2.1 Study 1: The effects of Tualang honey on single-high dose exposure of 
paraquat in rats (acute toxicity study) 
The general objective for study 1 is to evaluate the possible protective effect of 
Tualang honey in acute PQ poisoning. The specific objectives for study 1 include: 
(i) To determine the dose of PQ that contributes to severe signs of toxicity 
following a week of its administration to rats.  
(ii) To determine the dose of Tualang honey that can ameliorate PQ-intoxication 
in rats.  
(iii) To determine the effects of single and multiple doses of Tualang honey 
treatments based on the survival rate at 28 days following PQ-intoxication in 
rats. 
(iv) To determine the effects of single and multiple doses of Tualang honey 
treatments on the lung, kidney and liver’s histological changes of PQ-
intoxicated rats.   
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1.2.2 Study 2: The effects of Tualang honey on repeated-low dose exposures of 
paraquat in rats (subacute toxicity study) 
The general objective for study 2 is to evaluate the possible protective effects of 
Tualang honey in the midbrain region and lungs of rats exposed to four weekly 
administration of PQ. The specific objectives for study 2 include: 
(i) To determine the effects of Tualang honey on serum biochemical profiles of 
rats exposed to four weekly administration of PQ. 
(ii) To determine the effects of Tualang honey on the oxidative stress parameters 
and tyrosine hydroxylase levels in the midbrain of rats exposed to four 
weekly administration of PQ. 
(iii) To determine the effects of Tualang honey on immunohistochemical 
detection of tyrosine hydroxylase in the substantia nigra pars compacta region 
of rats exposed to four weekly administration of PQ. 
(iv) To determine the effects of Tualang honey on oxidative stress parameters and 
histological changes in the lung of rats exposed to four weekly administration 
of PQ. 
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CHAPTER 2  
LITERATURE REVIEW 
2.1 PARAQUAT 
2.1.1 History and uses 
Paraquat (PQ) or 1,1’-dimethyl-4,4’-bipyridinium, is a synthetic quaternary 
ammonium compound first described by Weidel and Rosso in 1882. The redox 
poperties of PQ was discovered by Michaelis and Hill (1933) in 1933. In the early 
years PQ was commonly called methyl viologen and was used as a redox indicator. 
This is because PQ dication (PQ
2+
) readily undergoes single electron reduction to 
form a stable free radical monocation (PQ˙+) with blue or violet colours (Krieger, 
2001). However, its herbicidal properties were only discovered in 1955 and finally it 
was first introduced to the market as a herbicide in 1962 by Imperial Chemical 
Industries Limited (ICI, now Syngenta). PQ is usually formulated as the dichloride 
salt. Although the patent protection on PQ has expired, Syngenta, one of the world’s 
largest agrochemical companies, remains the major manufacturer for PQ under the 
trade name Gramoxone®, accounting for at least 50% of its total world market 
(Dinham, 2003; Wesseling et al., 2001).  
 
PQ is a non-selective, fast-acting contact herbicides applied for wide spectrum 
control of broad-leaved and grassy weeds, but have no effects on matured bark. It is 
used on over 100 crops in approximately 100 countries, some of which includes 
United States of America, China, Mexico, Thailand, Malaysia and Japan (Syngenta, 
2015; Wesseling et al., 2001). Its frequent application in a wide variety of plantation 
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crops have been reported to increase agricultural productivity in both developed and 
developing countries (Carlile, 2006; Centers for Disease Control and Prevention, 
2003; IPCS, 1984).  
2.1.2 Mode of action as herbicide 
PQ exerts its herbicidal activity through the disruption of the normal electron flow in 
photosystem I which in turn inhibits the light reaction of photosynthesis. Once in the 
chloroplast where photosynthesis occurs, the positively charged PQ ion reacts with 
the free electron from photosystem I to produce PQ radicals. The radicals then react 
with oxygen to form various reactive oxygen species (ROS) which attack the 
unsaturated fatty acids of membranes, resulting in the destruction of membrane 
integrity and eventually cell death. Therefore, PQ is also known as cell membrane 
disruptors (Ashton and Crafts, 1981). 
2.1.3 Paraquat toxicity 
Despite its beneficial effects in agriculture, PQ is toxic to human and animals. Since 
its introduction in the early 1960’s, fatalities due to intentional, accidental or 
occupational exposure to PQ have been frequently reported (IPCS, 1984; WHO, 
2010). PQ is classified by the World Health Organization (WHO, 2010) as class II or 
moderately hazardous pesticide for acute toxicity based on its oral median lethal dose 
(LD50) in rat (150 mg/kg).  It is of relatively low hazard when used with adequate 
personal protective measures. However, serious delayed side effects may be 
developed which may even be fatal when the concentrated product is orally ingested 
or become in direct contact with the skin (WHO, 2010). The US Environmental 
Protection Agency (EPA) classified PQ dichloride into different categories of acute 
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toxicity based on the type of administration route i.e. highly toxic (category I) by 
inhalational route, moderately toxic (category II) by oral route, slightly toxic 
(category III) by dermal route; moderate to severe eye irritation (category II), and 
minimal dermal irritation (category IV)  (Environmental Protection Agency, 1997).  
2.2 TOXICOKINETICS OF PARAQUAT 
The intact skin is relatively impermeable to PQ but dermal absorption is enhanced 
when the skin is damaged (Wester et al., 1984). Most cases of PQ poisonings 
however, results from oral ingestion. A rapid but incomplete absorption of ingested 
PQ occurs mainly from the small intestine. In human, it is estimated that only less 
than five per cent of the ingested amount reach the bloodstream over one to six hours 
following its ingestion (Houze et al., 1990).  
 
Regardless of its route of administration into the mammalian systems, PQ is rapidly 
distributed via the blood circulation to all organs and tissues of the body although its 
storage is not prolonged in any tissues, since it is being eliminated by the kidneys 
between days and weeks. The absorbed PQ is largely (> 90%) excreted as a parent 
compound through the kidneys within 24 hours if normal kidney function is retained. 
Disturbance of normal renal function following high ingestion doses may cause renal 
tubular necrosis which in turn affects the elimination-distribution and accumulation 
in other organs (Hawksworth et al., 1981). Houze et al. (1990) described a bi-
exponential plasma concentration-time curve, with the initial and late phases of 
elimination half-lives being five and 84 hours, respectively. Plasma PQ is then 
selectively concentrated in the lungs via an energy-dependent process due to its 
structural similarity with naturally-occurring polyamines (such as putrescine, 
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cadaverine, spermidine and spermine) following which it is taken up by the alveolar 
cells (Fung et al., 1999) and exerts its major pneumotoxic effects. The structures of 
PQ and diamine putrescine are shown in Figure 2.1. 
2.3 MECHANISM OF PARAQUAT TOXICITY  
The main suggested mechanism for PQ toxicity is its ability to undergo cellular 
redox cycling with the subsequent production of various ROS (Bus and Gibson, 
1984). Similar to its herbicidal mode of action, PQ
2+
 is readily reduced to mono-
cation radical (PQ˙+)  by several enzymes including NADPH-cytochrome P450 
reductase, xanthine oxidase, NADH-ubiquinone oxidoreductase (complex I of 
mitochondrial respiratory chain) and nitric oxide synthase (Day et al., 1999; 
Fukushima et al., 1993; Han et al., 2006; Kitazawa et al., 1991; Tawara et al., 1996; 
Winterbourn and Button, 1984). PQ˙+ is then rapidly re-oxidized to its original 
dicationic form in the presence of oxygen (electron acceptor). During the process, 
superoxide radical is generated at the expense of NADPH (electron donor). Further 
redox cycling of PQ leads to generation of other ROS including hydrogen peroxide 
and hydroxyl radical. Consequently, depletion of cellular NADPH may result in the 
disturbance of NADPH-requiring biochemical processes. Furthermore, ROS can 
induce oxidative damage to lipids, proteins and nucleic acids (Bus and Gibson, 1984; 
Dinis-Oliveira et al., 2008; Lascano et al., 2012). Schematic representation of 
mechanism of PQ toxicity is illustrated in Figure 2.2.  
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Figure 2.1 Structures of paraquat and putrescine showing the geometric 
standards of the distance between nitrogen (N) atoms. The substrate selectivity for 
polyamine uptake system includes two (or more) charged nitrogens, an ideal distance 
between the nitrogen and a nonpolar spacer to separate these charges (Boelsterli, 
2007; Dinis-Oliveira et al., 2008) 
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Figure 2.2 Schematic representation of the mechanism of paraquat toxicity. (Abbreviations: CAT, catalase; GPx, glutathione peroxidase; GR, 
glutathione reductase; GSH, reduced glutathione; GSSG, glutathione disulfide; H2O2, hydrogen peroxide; HWR, Haber-Weiss reaction; FR, 
Fenton reaction; NADP
+
, nicotinamide adenine dinucleotide phosphate; NADPH, reduced nicotinamide adenine dinucleotide phosphate; O2, 
oxygen; O2˙
-
, superoxide anion; ˙OH, hydroxyl radical; PQ2+, paraquat;  PQ˙+, paraquat mono-cation radical; ROS, reactive oxygen species; 
SOD, superoxide dismutase) [Adapted from Dinis-Oliveira et al. (2008)]. 
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PQ-induced generation of ROS and the subsequent oxidative stress reactions occur in 
most organs. However, the toxic effects of PQ are particularly severe in the lungs 
due to its selective accumulation through the polyamine uptake system. There are 
two distinct phases in the development of pulmonary fibrosis by PQ. In the early 
destructive phase, the alveolar types I and II epithelial cells are damaged, resulting in 
a second proliferative phase defined by alveolitis and finally leading to an extensive 
lung fibrosis (Bus and Gibson, 1984). Pulmonary damage is manifested by oedema, 
haemorrhage, infiltration of inflammatory cells into the interstitial and alveolar 
spaces and proliferation of bronchial epithelium. Eventually, individuals die of 
respiratory failure (Bus and Gibson, 1984; Dinis-Oliveira et al., 2008; Ghazi-
Khansari et al., 2005; Smith et al., 1990; Suntres, 2002) (Figure 2.3). 
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Figure 2.3 Pathogenesis of paraquat-induced lung toxicity.[Adapted from Dinis-
Oliveira et al. (2008) and Matthay et al. (2012)]  
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2.4 ACUTE HEALTH EFFECTS OF PARAQUAT 
Acute pesticide poisoning, often due to single-high level exposure, is one of the 
major health concerns of pesticide usage. Globally, suicides or intentional self-
poisoning is considered as a major contributing factor for acute pesticide poisoning 
(Jeyaratnam, 1990). The estimated number of suicides in the year 2012 were 804 000 
worldwide with 75.5% of the global suicides occurring in the low and middle income 
countries including Africa, Central America, South-East Asia and the Western 
Pacific regions (WHO, 2014). Pesticide self-poisoning is one of the three most 
common methods for suicide, accounting for approximately 30% of the global 
suicides, especially in the rural agricultural areas of low and middle income countries 
(WHO, 2014). Besides intentional poisonings, it has also been reported that an 
estimated 355,000 fatalities occurred due to unintentional poisonings worldwide 
(WHO, 2003).  
 
Due to its popularity and ease of access, PQ is extensively used as a suicide agent 
particularly among developing countries (Gunnell and Eddleston, 2003; Jeyaratnam, 
1990; Wesseling et al., 2001). Nevertheless, a study by Seok et al. (2009) showed 
that only 38% of parasuicidal subjects intentionally select PQ suggesting that almost 
two-thirds of the subjects who ingested PQ occurred simply due to its wide 
availability during suicide attempts. On the other hand, accidental and occupational 
exposures to PQ were often associated with inappropriate use of pesticides, the lack 
of personal protective equipment or safety instructions on containers as well as 
accidental contamination with herbicide (Eddleston and Bateman, 2007; Eddleston et 
al., 2002; Van Wendel de Joode et al., 1996).  
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In Malaysia, almost three quarters (73.4%) of poisoning involving PQ were due to 
suicides, followed by accidental poisoning (13.8%) and occupational exposure 
(1.07%) (Jeyaratnam, 1990).  Similar findings were reported between the year 2000 
and 2006, where most chemical poisonings in Malaysia were parasuicidal, followed 
by accidental, homicidal and occupational-related poisonings where PQ is one of the 
main pesticides involved (MOH, 2006; Sirajuddin et al., 2001). Poisoning (together 
with injury and other consequences of external causes) has been reported to be 
among the top ten reasons of hospitalisation and mortality in government hospitals in 
Malaysia (MOH, 2010; MOH, 2012). For instance, the review on the medical records 
of 79 PQ poisoning cases admitted to Hospital Taiping, Perak between January 2008 
and October 2011 showed that 69.6% were of intentional exposure, followed by 26.6% 
accidental and 3.8% occupational exposures (Tan et al., 2013).  
 
Since pesticide poisoning accounts for nearly one-third of global suicides, it is 
suggested that death can be prevented if the use of toxic pesticides was restricted, or 
the access reduced through proper storage or disposal by individuals or communities. 
In addition, optimizing the medical management and the quality of care for poisoning 
cases are necessary (Gunnell et al., 2007).  
 
In an effort to reduce the accessibility of this highly toxic herbicide, beginning from 
August 2002, the Malaysian government has decided to ban PQ’s use while all other 
previously registered PQ products would be phased out in stages by November 2007. 
However, the ban was lifted in November 2006 and registration of PQ was allowed 
for all crops (Krishnamoorthy, 2006). To date, 59 pesticides which contain PQ 
dichloride as an active ingredient are registered by the Pesticides Board, Department 
of Agriculture (DOA), Malaysia from February 2010 to January 2015 (DOA, 2015a). 
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Nevertheless, as of 2014, the use of herbicides containing PQ was restricted only to 
weed control in palm oil, rubber or dry paddy plantations as well as for killing of 
pineapple stumps only with its use forecasted to be banned again by the year 2020 
(DOA, 2015b).  
2.4.1 Clinical classification of acute paraquat poisoning 
Clinical experiences of treating PQ-intoxicated patients help to predict the prognosis 
of PQ poisoning. Generally, the severity of PQ poisoning can be classified into three 
categories: mild, severe or acute fulminant poisoning. Patients who experienced mild 
poisoning, with an estimated ingestion of less than 20 mg PQ ion per kg body weight 
(or < 7.5 mL of 20% formulation for a 70 kg person), is often asymptomatic or may 
develop minor gastrointestinal symptoms such as vomiting and diarrhoea. However, 
in these cases, full recovery usually occurs (Vale et al., 1987).  
 
In cases of moderate to severe poisonings, with estimated ingestion of 20 to 40 mg 
PQ ion per kg body weight (or 7.5 – 15 mL of 20% formulation for a 70 kg person), 
patients may initially suffer from gastrointestinal symptoms, followed by multiple 
organs injuries. Proximal tubular dysfunction usually evolved and with renal 
insufficiency often noted, which may further affect the main route of PQ elimination 
and contribute to poor prognosis (Gil et al., 2005). In addition, liver toxicity as 
revealed by associated biochemical abnormalities may also occur. Centrilobular 
hepatic necrosis and cholestasis are usually seen during postmortem examination of 
patients having impaired liver function (Dinis-Oliveira et al., 2008). Death usually 
occurs in most cases. Nevertheless, patients who survived acute poisoning often 
developed pulmonary fibrosis, resulting in delayed death which usually occurs within 
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two to four weeks as a result of respiratory failure and is often fatal (Lock and Wilks, 
2010; Vale et al., 1987).  
 
In cases of fulminant poisoning, with an estimated ingestion of more than 40 mg 
paraquat ion per kg body weight (or > 15 mL of 20% formulation for a 70 kg person), 
the mortality is almost 100%. Death usually occurs within the same day or no longer 
than a few days due to multiple organ failure where patients usually succumb before 
the development of pulmonary fibrosis (Reigart, 2009; Sabzghabaee et al., 2010; 
Vale et al., 1987).  
2.4.2 Clinical management of paraquat poisoning 
Clinically, there is no specific antidote for PQ poisoning. Athough a wide variety of 
therapies have been extensively studied, the mortality rate remains high with 
indeterminate treatment efficacies (Hong et al., 2014; Nagami et al., 2013). 
Therefore, the goal is to relieve symptoms and treat complications (i.e. to provide a 
supportive care). Conventional approaches in treating PQ poisoning include 
prevention of absorption from the gastrointestinal tract, enhanced elimination of PQ 
from the body and instituting therapy directed against toxicity symptomatically 
(Gawarammana and Buckley, 2011; Gil et al., 2014).  
 
The initial treatment of poisoning usually consists of administrations of oral 
absorbents such as Fuller’s earth, activated charcoal or bentonite, all of which are 
aimed at neutralizing PQ in the gastrointestinal tract and enhancing its excretion in 
the faeces by using purgatives, mannitol or gastric lavage. For instance, routine 
treatment with multiple doses of activated charcoal also yielded no clinical benefit 
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with similar mortality rate compared to the non-charcoal treated groups (Eddleston et 
al., 2008). Gastric lavage may be considered for patients who presented within an 
hour of ingestion of potentially life-threatening amount of PQ (Vale, 1997). 
However, serious complications which include hypoxia, gastrointestinal tract or 
pharynx perforation, disturbances of fluid and electrolytes balances may also occur 
(Benson et al., 2013; Vale and Kulig, 2004).  
 
Haemoperfusion, haemodialysis, haemofiltration and forced diuresis may be used to 
enhance excretion of systematically absorbed PQ or allow stabilization of 
haemodynamic status of patients with multiorgan failures (Gao et al., 2015; 
Gawarammana and Buckley, 2011). A combined therapy with haemoperfusion and 
continuous venovenous haemofiltration may prolong the survival time and reduce the 
number of early deaths due to multiorgan failures, thus providing an opportunity for 
further treatment. However, the mortality rate remains high and patients eventually 
die from respiratory failure (Gao et al., 2015; Koo et al., 2002).  
 
Other supportive therapies include surgical approaches (lung transplantation) and 
radiotherapy (to prevent fibroblast proliferation and ultimate interstitial fibrosis) to 
the diseased lungs although they have not been proven to be effective (Franzen et al., 
1991). There are some reports that pulse immunosuppression with the use of 
methylprednisolone and cyclophosphamide can help prevent lung fibrosis in PQ-
intoxicated patients although further confirmation with clinical trials are still required 
(Koh et al., 2014; Lin et al., 2006; Lin et al., 1996).  
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Current researches on PQ poisoning have also been directed towards the use of 
antioxidants, since PQ induces its toxic effect through oxidative stress-mediated 
mechanisms. For example, the use of superoxide dismutase (SOD) in PQ intoxication 
allows the conversion of highly toxic superoxide anions to potentially less toxic 
hydrogen peroxide and water. However, the finding from a study has demonstrated 
that administration of SOD by continuous intravenous infusion failed to improve 
PQ’s toxic effects (Block, 1979). SOD also failed to protect against PQ poisoning in 
vitamin E-deficient animals, possibly because in the absence of vitamin E, 
peroxidative chain reactions are triggered and sustained by small amount of 
superoxide anion escaping detoxification by SOD (Block, 1979). Moreover, SOD 
cannot enter the target membrane or can hardly adhere to the targets due to its high 
molecular mass and charge (Ilizarov et al., 2001; Suntres, 2002).  
 
Other antioxidants investigated in search of the treatment for PQ poisoning include 
vitamins C and E, melatonin, iron chelators, low molecular weight thiol-containing 
antioxidants [e.g. glutathione (GSH), N-acetylcysteine, metallothionein] and mono-
unsaturated fatty acids. However, most of the antioxidants failed to modify PQ’s 
toxicity which is attributed by their inability to cross cell membrane barriers and/or 
due to their rapid clearance from cells (Suntres, 2002). More recently, the use of 
liposomal antioxidants (e.g. liposome-entrapped GSH and α-tocopherol liposomes) 
or low molecular weight SOD mimetics leads to increased therapeutic potentials 
against PQ pulmonary toxicity since they presumably facilitate the intracellular 
delivery. Therefore, much remains to be known about the use of intracellular and 
extracellular antioxidants in PQ toxicity with no single strategy appearing to show 
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improvement in the outcome for PQ poisoning (Suntres, 2002) indicating that there is 
still a need to search for new treatment modalities. 
2.5 CHRONIC HEALTH EFFECTS OF PARAQUAT 
In addition to the above, the possible delayed health effects from long term-low dose 
exposure is another major health concern of pesticide use particularly due to 
occupational exposure by the workers who were exposed to PQ for a long period of 
time. Additionally, chronic low dose exposures to PQ may also cause adverse 
respiratory effects among the workers. A study conducted among PQ workers in the 
Western Cape, South Africa indicated that under the usual field conditions, working 
with PQ over a long period of time is associated with desaturation of arterial oxygen, 
especially during exercise (Dalvie et al., 1999). Castro-Gutierrez et al. (1997) 
reported an increase in the prevalence of respiratory symptoms among the workers. 
Analysis of blood samples from PQ-formulating factory workers have been reported 
to show increased in lipid peroxidation and decreased in antioxidant power (Ranjbar 
et al., 2002).  
2.5.1 Paraquat neurotoxicity 
In addition to its well-known pneumotoxic effects, the possible chronic neurotoxic 
effects of PQ have gained a wide interest over the past two decades due to its 
structural similarity with 1-methyl-4-phenylpyridinium ion (MPP
+
) (Tieu, 2011; Wu 
et al., 2012) (Figure 2.4). MPP
+
 is an active metabolite of 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) with known dopaminergic neurotoxic effect contributing 
to acute Parkinsonism in human (Langston et al., 1983; Shimizu et al., 2003b). The 
by-product from synthetic heroin is not naturally found in the environment as 
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compared to the widely used herbicide PQ, further supported by human 
epidemiological studies which found that chronic exposure to pesticides including 
PQ, particularly among agricultural workers are associated with significantly higher 
incidence of Parkinson’s disease (Hertzman et al., 1990; Liou et al., 1997; Petrovitch 
et al., 2002).  
 
 
Figure 2.4 Structures of paraquat, MPTP and its active metabolite MPP
+
. 
(Abbreviations: MPP+, 1-methyl-4-phenylpyridinium ion; MPTP, 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine). 
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2.5.2 Paraquat-induced oxidative stress-related neuronal damage 
In an animal experimental model, a single PQ exposure did not induce any 
neurodegeneration in mice but can lead to microglial activation, making neurons 
more susceptible to damage following subsequent exposures  (Purisai et al., 2007). In 
an effort to understand the toxicokinetics of PQ in the brain, a study by Prasad et al. 
(2009) reported that PQ persists in the ventral midbrain with an estimated half-life of 
approximately 28 days, irrespective of its route of administration. The prolonged 
persistence suggests that accumulation of PQ following its repeated exposure is 
expected (Prasad et al., 2009). Furthermore, systemic exposures of PQ in the rats or 
mice can induce selective dopaminergic neurodegeneration in the midbrain 
substantia nigra (SN) i.e. one of the neuropathological hallmarks of Parkinson’s 
disease. In addition, dopamine depletion and increased levels of α-synuclein protein 
aggregation were also reported (Fernagut et al., 2007; Manning-Boğ et al., 2003; 
Wills et al., 2012). 
 
The brain naturally contains relatively low levels of antioxidants with high amounts 
of polyunsaturated fatty acids making it more susceptible to oxidative injuries due to 
redox imbalance. Of the brain’s neuronal cell types, the dopaminergic neurons in the 
nigrostriatal system are selectively vulnerable to oxidative injury because dopamine 
metabolism itself can generate high levels of ROS (Chinta and Andersen, 2008). The 
role of oxidative stress in PQ-induced dopaminergic neurodegeneration in the SN 
region have previously been reported (Kang et al., 2010; McCarthy et al., 2004; Peng 
et al., 2005; Somayajulu-Nitu et al., 2009), thus suggesting the use of antioxidants as 
one of the possible therapeutic approaches for neurodegenerative disorders. For 
example, the study by Peng et al. (2005) demonstrated a protective role of synthetic 
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SOD/catalase mimetics in PQ-induced neurotoxicity in both rat dopaminergic cell 
lines and in adult mice. In addition, administrations of the antioxidant coenzyme Q10 
(as known as ubiquinone) have also shown some neuroprotective effects in animal 
models of neurodegenerative disease (Cleren et al., 2008; Matthews et al., 1998; 
Somayajulu-Nitu et al., 2009). Human preliminary data suggested daily 
supplementation of coenzyme Q10 appears to slow the disease progression in early 
Parkinson’s disease (Shults et al., 2002). Nevertheless, no evidence of clinical 
benefit was observed in a phase III clinical trial in patients diagnosed with 
Parkinson’s disease within five years who received the coenzyme Q10 up to 16 
months intervention and observation (Beal et al., 2014), indicating its questionable 
effects. 
 
Meanwhile, a recent published report on Phase II clinical trial using ubiquinol 
showed significant improvement in Parkinson’s patient with wearing off (Yoritaka et 
al., 2015).  Ubiquinol, the reduced form of coenzyme Q10, was previously showed to 
be more effective in an MPTP-induced mouse model of Parkinson’s disease when 
compared to the same dose of coenzyme Q10 (oxidized form) tested (Cleren et al., 
2008).  It is the most common form of coenzyme Q10 in vivo accounts for more than 
80% of the total coenzyme Q10 (ubiquinol + ubiquinone) pool in human plasma, 
intestine and liver (Hosoe et al., 2007). When administered orally, ubiquinol showed 
a higher bioavailability than the oxidized form of coenzyme Q10 (Mae et al., 2001). 
However, the clinical efficacy for ubiquinol in Parkinson’s patients was yet to be 
confirmed in a larger clinical study.  
